Jefferies Financial Group Reduces AbbVie Stake

Institutional investor sells over 53,000 shares of pharmaceutical company

Published on Mar. 9, 2026

Got story updates? Submit your updates here. ›

Jefferies Financial Group Inc. has reduced its position in AbbVie Inc. (NYSE:ABBV) by 34.8% during the third quarter, according to a recent 13F filing with the SEC. The institutional investor now owns 99,673 shares of the company's stock, down from 152,796 shares previously.

Why it matters

This transaction provides insight into the investment strategy of Jefferies Financial Group, a major institutional investor. Changes in large investor holdings can signal shifts in market sentiment or confidence around a particular stock.

The details

According to the 13F filing, Jefferies Financial Group sold 53,123 shares of AbbVie stock during the third quarter. The firm's remaining stake in AbbVie is valued at $23,078,000 as of the most recent reporting period.

  • Jefferies Financial Group reduced its AbbVie position during the 3rd quarter of 2026.

The players

Jefferies Financial Group Inc.

A global investment banking firm and institutional investor.

AbbVie Inc.

A research-driven biopharmaceutical company that develops and commercializes therapies for complex and chronic medical conditions.

Got photos? Submit your photos here. ›

The takeaway

This transaction suggests Jefferies Financial Group may have reduced its exposure to AbbVie, potentially due to a shift in the firm's investment strategy or outlook on the pharmaceutical sector. However, without additional context, it's difficult to draw firm conclusions about the motivations behind the portfolio adjustment.